NEW YORK & TONGHUA, China--(BUSINESS WIRE)--BioPharm Asia, Inc. (OTCBB: BFAR), a producer, distributor and retailer of medical products in China, today reported its financial results for the full year ended December 31, 2009. The finalization of these results was delayed due to the February 2010 appointment of Davis Accounting Group P.C. as the Company’s auditor.
